Prof Sangil Park, Department of Neurology, Uijeongbu Eulji Medical Center, South Korea
Prof. Sangil Park is a dedicated neurologist and clinical researcher with expertise in stroke, neurocritical care, and neuro-intervention. 🧠💉 He serves as a Clinical Assistant Professor at Uijeongbu Eulji Medical Center and has completed fellowships in radiology, neurology, and critical care. 🌟📚 Holding a Ph.D. from Kyung Hee University, Dr. Park is certified in neurology, acute stroke care, and critical care medicine. 🎓🏅 His research includes innovative treatments for vascular diseases and digital health applications. 🩺📊 An active member of multiple neurological societies, he has published extensively and presented at international conferences. 🌍📝 Dr. Park’s work reflects a passion for advancing neurological care. ✨
Publication Profile
Orcid
Education
Prof. Sangil Park boasts an impressive educational journey and certifications in medicine and engineering. He earned his Ph.D. in Medicine from Kyung Hee University (2023) 🧑🎓, where he also completed his M.D. (2014) 🩺. Prior to this, he obtained a B.D. in Electrical Engineering and Computer Science from Hanyang University (2009) 💻. Prof. Park holds the Korean Board of Neurology (2022) 🧠, the Certification of TPI from The Korean Orthopedic Pain Society (2022) 🏥, and the Subspecialty Board of Critical Care Medicine (2024) 🫀. Additionally, he is a certified Acute Stroke Neurologist (2024) ⚡, blending expertise in neurology and technology.
Career Background
Prof. Sangil Park is a dedicated neurologist with extensive clinical experience and academic achievements. Since March 2024, he has been serving as a Clinical Assistant Professor at Uijeongbu Eulji Medical Center 🏥. He previously held fellowships in Radiology at Asan Medical Center (2023-2024) and in Neurology and Critical Care Medicine at Kyung Hee University Medical Center (2022-2023) 🔬🧠. Prof. Park completed his Neurology residency at Kyung Hee University Hospital at Gangdong (2018-2022) and internship at Kyung Hee University Medical Center (2017-2018) 👨⚕️. His military service included working as a public health doctor in Changnyeong-gun (2014-2017) 🚑🇰🇷.
Experience
Prof. Sangil Park’s groundbreaking work focuses on neurological and cerebrovascular health through advanced clinical research. 🌟🧠 He led a post-marketing safety study on Emgality (Galcanezumab) for migraine prophylaxis in adults in Korea (SIT, PMS2020-014-005) 💊, and explored neuroprotection with neu2000 in acute ischemic stroke patients through a phase-III randomized trial (2021-10-090). 🔬 In another study, he evaluated atrial fibrillation’s prevalence and impact in elderly patients with cryptogenic stroke and patent foramen ovale (2021-04-034). 💓 His contributions extend to assessing Choline Alfoscerate’s safety and efficacy in mild cognitive impairment with cerebrovascular disease in a phase-IV trial (2021-07-094). 🧪📈
Presentation
Prof. Sangil Park has contributed extensively to stroke and neurovascular research. Key presentations include delayed post-hypoxic leukoencephalopathy after ischemic stroke at the 15th ESMINT Congress (2023) 🧠, and styloidogenic jugular venous compression syndrome at the Asia Pacific Stroke Conference (2022) 🩺. His studies on carotid artery restenosis after stenting at the 14th World Stroke Congress (2022) and predictors of in-stent restenosis at the KSIN Summer Intensive Course (2024) provide valuable insights 📊. Prof. Park has also explored COVID-19 vaccination’s link to ischemic stroke 🦠 and innovative treatments for cavernous sinus dural AVFs (2023) 🩸, advancing neurovascular care worldwide. 🌍
Professional Recognition
Prof. Sangil Park is a dedicated neurologist with memberships in multiple prestigious societies, reflecting his commitment to advancing the field. 🌍📚 His consistent focus on cutting-edge research has significantly contributed to the understanding and treatment of neurological conditions. 🧠🔬 Specializing in stroke and neurocritical care, Prof. Park has made impactful strides in improving patient outcomes through collaborative research efforts. 🤝💡 His work bridges innovation and clinical application, ensuring better care for patients worldwide. 🏥🌟 A true leader in neurology, he continues to inspire progress in the field, shaping the future of neuroscience and neurocritical care. 🚀✨
Research Focus
Prof. Sangil Park’s research primarily focuses on neurovascular diseases, endovascular treatments, and innovative diagnostic approaches. His studies include targeted embolization for cavernous sinus dural arteriovenous fistulas 💉🧠, advanced imaging markers like the HARM sign for transient ischemic attacks 🩻🚨, and real-world applications of digital health technologies for chronic conditions like hypertension and diabetes 📱💊. His work extends to rare conditions, such as medullary hemangioblastomas and cerebral vasculitis 🩸🧬, reflecting a broad interest in improving patient outcomes through multidisciplinary approaches. His contributions to neurosonology and embolization emphasize precision medicine in neurology and radiology. 🌟📚
Publication Top Notes